Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03928483 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
A Early Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 143
- Enrollment target
NCT03928483: Completed Early Phase 1 study, sponsored by Medical University of South Carolina.
NCT03928483 is a Early Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 143 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (170% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03928483, a Early Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 143 participants
- Enrollment target
Study Summary
To examine weight loss and acceptability of a modified WW program. This study is designed to detect differences in weight loss at the end of 24 weeks of intervention.
Primary Outcome
average body weight change (kg) from baseline to six months
Interventions
- BEHAVIORAL Modified WW Food program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2019-11-07 |
| Phase | Early Phase 1 |
What the finished NCT03928483 record still lists
NCT03928483 is an interventional study that assigns participants to a tested intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (170% higher).
The record links to 0 conditions, and to 1 intervention - of which Modified WW Food program is the first listed.
NCT03928483 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03928483 about?
NCT03928483 is a clinical study titled "Evaluation of a Commercial Program on Weight Loss and Health Outcomes". To examine weight loss and acceptability of a modified WW program. This study is designed to detect differences in weight loss at the end of 24 weeks of intervention.
What is the current status of trial NCT03928483?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 143 participants. The study started on 2019-03-18. Estimated completion is 2019-11-07.
What interventions are being tested in trial NCT03928483?
The interventions under investigation include: Modified WW Food program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03928483?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03928483's enrollment target sits among peer trials
143 112th of 2000 higher than 1,887 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI